相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Manipulations of phenylnorbornyl palladium species for multicomponent construction of a bridged polycyclic privileged scaffold
Lina Yin et al.
COMMUNICATIONS CHEMISTRY (2022)
Design, Synthesis, and Biological Evaluations of Pyridyl 4,5,6,7-Tetrahydro-4,7-Methanobenzo[d]isoxazoles as Potent and Selective Inhibitors of 11β-Hydroxylase
Lina Yin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects
Qichao Hu et al.
PHARMACOLOGICAL RESEARCH (2021)
Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway
Tian Lan et al.
HEPATOLOGY (2021)
Natural products in drug discovery: advances and opportunities
Atanas G. Atanasov et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis
Wenyi Liang et al.
FRONTIERS IN PHARMACOLOGY (2021)
The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease
F. Anthony Romero et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Nonalcoholic Steatohepatitis: A Review
Adam C. Sheka et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice
Aline David-Silva et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
Ginsenoside Rg1 Regulates Liver Lipid Factor Metabolism in NAFLD Model Rats
Yunhe Hou et al.
ACS OMEGA (2020)
20S-Protopanaxatriol Ameliorates Hepatic Fibrosis, Potentially Involving FXR-Mediated Inflammatory Signaling Cascades
Jian Song et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2020)
Vitexin ameliorates chronic stress plub high fat diet-induced nonalcoholic fatty liver disease by inhibiting inflammation
Chujie Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Formononetin ameliorates cholestasis by regulating hepatic SIRT1 and PPARα
Shu Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Genistein can ameliorate hepatic inflammatory reaction in nonalcoholic steatohepatitis rats
Yimin Yin et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Kaempferol attenuates liver fibrosis by inhibiting activin receptor-like kinase 5
Taifu Xu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Betulinic acid alleviates endoplasmic reticulum stress-mediated nonalcoholic fatty liver disease through activation of farnesoid X receptors in mice
Ming Gu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Berberine Directly Affects the Gut Microbiota to Promote Intestinal Farnesoid X Receptor Activation
Yuan Tian et al.
DRUG METABOLISM AND DISPOSITION (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
Antifibrotic effects of Fraxetin on carbon tetrachloride-induced liver fibrosis by targeting NF-κB/IkBα, MAPKs and Bcl-2/Bax pathways
Bin Wu et al.
PHARMACOLOGICAL REPORTS (2019)
Identification of an Oleanane-Type Triterpene Hedragonic Acid as a Novel Farnesoid X Receptor Ligand with Liver Protective Effects and Anti-inflammatory Activity
Yi Lu et al.
MOLECULAR PHARMACOLOGY (2018)
Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo
Lingli Zheng et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Grape Leucoanthocyanidin Protects Liver Tissue in Albino Rabbits with Nonalcoholic Hepatic Steatosis
Reginaldo Franklin et al.
CELLS TISSUES ORGANS (2018)
Silybin inhibits NLRP3 inflammasome assembly through the NAD+/SIRT2 pathway in mice with nonalcoholic fatty liver disease
Bangling Zhang et al.
FASEB JOURNAL (2018)
Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation
Weiwei Chen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice
Junli Zhang et al.
LIFE SCIENCES (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway
Hong Yao et al.
PHARMACOLOGICAL RESEARCH (2018)
Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK/NOX4/PI3K/AKT pathway
Jiting Yan et al.
PHARMACOLOGICAL RESEARCH (2018)
Natural product andrographolide alleviated APAP-induced liver fibrosis by activating Nrf2 antioxidant pathway
Hongyu Yan et al.
TOXICOLOGY (2018)
Hepatoprotective effect of bisbenzylisoquinoline alkaloid tiliamosine from Tiliacora racemosa in high-fat diet/diethylnitrosamine-induced non-alcoholic steatohepatitis
S. Sylvester Darvin et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
beta-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice
Zoltan V. Varga et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
Runbin Sun et al.
MOLECULAR PHARMACOLOGY (2017)
Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease
Majid Bahabadi et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2017)
(-)-Epicatechin regulates blood lipids and attenuates hepatic steatosis in rats fed high-fat diet
Hui Cheng et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2017)
Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling
Ming Gu et al.
PHARMACOLOGICAL RESEARCH (2017)
Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor
Xingping Duan et al.
PHYTOMEDICINE (2017)
Potential of the chlorogenic acid as multitarget agent: Insulin-secretagogue and PPAR α/γ dual agonist
Maetzin Becerra Sanchez et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Natural alkaloid bouchardatine ameliorates metabolic disorders in high-fat diet-fed mice by stimulating the sirtuin 1/liver kinase B-1/AMPK axis
Yong Rao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways
Xu-qiang Nie et al.
ACTA PHARMACOLOGICA SINICA (2016)
Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress
Xiaoyan Qiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Discovery of natural alkaloid bouchardatine as a novel inhibitor of adipogenesis/lipogenesis in 3T3-L1 adipocytes
Yong Rao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Ursolic acid improves lipid and glucose metabolism in high-fat-fed C57BL/6J mice by activating peroxisome proliferator-activated receptor alpha and hepatic autophagy
Yaoyao Jia et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2015)
trans-Caryophyllene is a natural agonistic ligand for peroxisome proliferator-activated receptor-α
Chunyan Wu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Rutaecarpine Analogues Reduce Lipid Accumulation in Adipocytes via Inhibiting Adipogenesis/Lipogenesis with AMPK Activation and UPR Suppression
Ying-Chun Chen et al.
ACS CHEMICAL BIOLOGY (2013)
Antidiabetic Effects of Pterosin A, a Small-Molecular-Weight Natural Product, on Diabetic Mouse Models
Feng-Lin Hsu et al.
DIABETES (2013)
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
Giovanni Musso et al.
PROGRESS IN LIPID RESEARCH (2013)
Promotion of adiponectin multimerization by emodin: A novel AMPK activator with PPARγ-agonist activity
Zhifen Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Leukamenin F suppresses liver fibrogenesis by inhibiting both hepatic stellate cell proliferation and extracellular matrix production
Qiong Liu et al.
ACTA PHARMACOLOGICA SINICA (2010)
The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease
Mi-Hyun Kim et al.
BRITISH JOURNAL OF NUTRITION (2010)
Structure-Activity Relationship Study of Betulinic Acid, A Novel and Selective TGR5 Agonist, and Its Synthetic Derivatives: Potential Impact in Diabetes
Cedric Genet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Novel PPAR-gamma agonists identified from a natural product library: A virtual screening, induced-fit docking and biological assay study
Noeris K. Salam et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2008)
Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-Ay mice
H Nozawa
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
A natural product that lowers cholesterol as an antagonist ligand for FXR
NL Urizar et al.
SCIENCE (2002)
分享论文
